AzTrials
AzTrials

Clinical trials: Neoantigen

What
Where
Study
Who can join
Dates
Clear all

1 study

  • Colorectal Cancer

    Safety and Immune Response to FMPV-1

    • Completed
    • Age: 18 to 55 years
    • Phase 1

    This is a single centre, open-label, non-randomized, Phase I study assessing safety and immune response of FMPV-1 in healthy male subjects.

    Trial name
    NCT05238558
    Testing
    FMPV-1, GM-CSF (as adjuvant)
    Where
    United Kingdom
    Volunteers
    16 people, healthy volunteers welcome
    Sponsor
    Hubro Therapeutics AS
    Can I take part? NCT05238558

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in